French ccAFU guidelines - update 2020-2022: upper urinary tract urothelial carcinoma

被引:0
作者
Roupret, M. [1 ,2 ]
Audenet, F. [1 ,3 ]
Roumiguie, M. [1 ,4 ]
Pignot, G. [1 ,5 ]
Masson-Lecomte, A. [1 ,6 ]
Comperat, E. [1 ,7 ]
Houede, N. [1 ,8 ]
Larre, S. [1 ,9 ]
Brunelle, S. [1 ,10 ]
Xylinas, E. [1 ,11 ]
Neuzillet, Y. [1 ,12 ]
Mejean, A. [1 ,2 ]
机构
[1] Assoc Francaise Durol, Com Cancerol, Grp Vessie, Maison Urol, 11 Rue Viete, F-75017 Paris, France
[2] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Predict Oncourol, GRC 5,83 Blvd Hop, F-75013 Paris, France
[3] Univ Paris 05, Serv Urol, Hop Europeen Georges Pompidou, AP HP, Paris, France
[4] CHU Rangueil, Dept Urol, Toulouse, France
[5] Inst Paoli Calmettes, Serv Urol, Marseille, France
[6] Univ Paris Diderot, Serv Urol, Hop St Louis, Paris, France
[7] Sorbonne Univ, Hop Tenon, Serv Anat Pathol, ONCOTYPE URO,HUEP, GRC 5, Paris, France
[8] Montpellier Univ, Dept Oncol Med, CHU Caremeau, Nimes, France
[9] CHU Reims, Serv Urol, Reims, France
[10] Inst Paoli Calmettes, Serv Radiol, Marseille, France
[11] Univ Paris 05, Hop Bichat Claude Bernard, AP HP, Serv Urol, Paris, France
[12] Univ Versailles St Quentin En Yvelines, Hop Foch, Serv Urol, Suresnes, France
来源
PROGRES EN UROLOGIE | 2020年 / 30卷 / 12期
关键词
Urothelial carcinoma; Urinary cytology; Ureter; Renal pelvis; Kidney; Cancer; Ureteroscopy; Survival; YEARLY SCIENTIFIC REPORT; OF-THE-ART; ARISTOLOCHIC ACID NEPHROPATHY; COMPUTED-TOMOGRAPHY UROGRAPHY; CISPLATIN-INELIGIBLE PATIENTS; CANCER-SPECIFIC SURVIVAL; INVASIVE BLADDER-CANCER; RADICAL NEPHROURETERECTOMY; NATIONAL ASSOCIATION; INTRAVESICAL RECURRENCE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - The purpose was to propose an update of the French guidelines from the national committee ccAFU on upper tract urothelial carcinomas (UTUC). Methods. - A systematic Medline search was performed between 2018 and 2020, as regards diagnosis, options of treatment and follow-up of UTUC, to evaluate different references with levels of evidence. Results. - The diagnosis of this rare pathology is based on CT-scan acquisition during excretion and ureteroscopy with histological biopsies. Radical nephroureterectomy (RNU) remains the gold standard for surgical treatment, nevertheless a conservative endoscopic approach can be proposed for low risk lesion: unifocal tumor, possible complete resection and low grade and absence of invasion on CT-scan. Close monitoring with endoscopic follow-up (flexible ureteroscopy) in compliant patients is therefore necessary. After RNU, bladder instillation of chemotherapy is recommended to reduce risk of bladder recurrence. A systemic chemotherapy is recommended after RNU in pT2-T4 NO-3 MO disease. Conclusion. - These updated guidelines will contribute to increase the level of urological care for diagnosis and treatment for UTUC. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S52 / S77
页数:26
相关论文
共 97 条
[1]   Update on MR urography (MRU): technique and clinical applications [J].
Abreu-Gomez, Jorge ;
Udare, Amar ;
Shanbhogue, Krishna P. ;
Schieda, Nicola .
ABDOMINAL RADIOLOGY, 2019, 44 (12) :3800-3810
[2]   Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes [J].
Audenet, Francois ;
Traxer, Olivier ;
Bensalah, Karim ;
Roupret, Morgan .
WORLD JOURNAL OF UROLOGY, 2013, 31 (01) :45-52
[3]   Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage [J].
Baboudjian, Michael ;
Al-Balushi, Khalid ;
Michel, Floriane ;
Lannes, Francois ;
Akiki, Akram ;
Gaillet, Sarah ;
Delaporte, Veronique ;
Ragni, Evelyne ;
Toledano, Harry ;
Karsenty, Gilles ;
Rossi, Dominique ;
Bastide, Cyrille ;
Lechevallier, Eric ;
Boissier, Romain .
WORLD JOURNAL OF UROLOGY, 2020, 38 (01) :159-165
[4]   First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study [J].
Balar, Arjun V. ;
Castellano, Daniel ;
O'Donnell, Peter H. ;
Grivas, Petros ;
Vuky, Jacqueline ;
Powles, Thomas ;
Plimack, Elizabeth R. ;
Hahn, Noah M. ;
de Wit, Ronald ;
Pang, Lei ;
Savage, Mary J. ;
Perini, Rodolfo F. ;
Keefe, Stephen M. ;
Bajorin, Dean ;
Bellmunt, Joaquim .
LANCET ONCOLOGY, 2017, 18 (11) :1483-1492
[5]   Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].
Balar, Arjun V. ;
Galsky, Matthew D. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Loriot, Yohann ;
Necchi, Andrea ;
Hoffman-Censits, Jean ;
Perez-Gracia, Jose Luis ;
Dawson, Nancy A. ;
van der Heijden, Michiel S. ;
Dreicer, Robert ;
Srinivas, Sandy ;
Retz, Margitta M. ;
Joseph, Richard W. ;
Drakaki, Alexandra ;
Vaishampayan, Ulka N. ;
Sridhar, Srikala S. ;
Quinn, David I. ;
Duran, Ignacio ;
Shaffer, David R. ;
Eigl, Bernhard J. ;
Grivas, Petros D. ;
Yu, Evan Y. ;
Li, Shi ;
Kadel, Edward E., III ;
Boyd, Zachary ;
Bourgon, Richard ;
Hegde, Priti S. ;
Mariathasan, Sanjeev ;
Thastrom, AnnChristine ;
Abidoye, Oyewale O. ;
Fine, Gregg D. ;
Bajorin, Dean F. .
LANCET, 2017, 389 (10064) :67-76
[6]   Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial [J].
Birtle, Alison ;
Johnson, Mark ;
Chester, John ;
Jones, Robert ;
Dolling, David ;
Bryan, Richard T. ;
Harris, Christopher ;
Winterbottom, Andrew ;
Blacker, Anthony ;
Catto, James W. F. ;
Chakraborti, Prabir ;
Donovan, Jenny L. ;
Elliott, Paul Anthony ;
French, Ann ;
Jagdev, Satinder ;
Jenkins, Benjamin ;
Keeley, Francis Xavier, Jr. ;
Kockelbergh, Roger ;
Powles, Thomas ;
Wagstaff, John ;
Wilson, Caroline ;
Todd, Rachel ;
Lewis, Rebecca ;
Hall, Emma .
LANCET, 2020, 395 (10232) :1268-1277
[7]   Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: Systematic review and meta-analysis [J].
Chlapoutakis, Konstantinos ;
Theocharopoulos, Nicholas ;
Yarmenitis, Spyros ;
Damilakis, John .
EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (02) :334-338
[8]   Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer [J].
Chung, Younsoo ;
Lee, Dong Hwan ;
Lee, Minseung ;
Kim, Hakju ;
Lee, Sangchul ;
Hong, Sung Kyu ;
Byun, Seok-Soo ;
Lee, Sang Eun ;
Oh, Jong Jin .
INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (02) :158-165
[9]   Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis [J].
Clements, Matthew B. ;
Krupski, Tracey L. ;
Culp, Stephen H. .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (09) :2550-2562
[10]   Follow-up of urothelial carcinoma: Review of the Cancer Committee of the French Association of Urology [J].
Colin, P. ;
Neuzillet, Y. ;
Pignot, G. ;
Roupret, M. ;
Comperat, E. ;
Lurre, S. ;
Roy, C. ;
Quintens, H. ;
Houede, N. ;
Soulie, M. ;
Pfister, C. .
PROGRES EN UROLOGIE, 2015, 25 (10) :616-624